Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis

Full text
Author(s):
Joaquim, Helena P. G. [1] ; Zanetti, Marcus V. [2, 3, 1] ; Serpa, Mauricio H. [2, 3, 1] ; Van de Bilt, Martinus T. [1] ; Sallet, Paulo C. [1] ; Chaim, Tiffany M. [2, 3] ; Busatto, Geraldo F. [2, 3] ; Gattaz, Wagner F. [2, 1] ; Talib, Leda L. [2, 1]
Total Authors: 9
Affiliation:
[1] Univ Sao Paulo, Dept & Inst Psychiat, Lab Neurosci LIM 27, Sao Paulo - Brazil
[2] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, Sao Paulo - Brazil
[3] Univ Sao Paulo, Dept & Inst Psychiat, Lab Psychiat Neuroimaging, LIM 21, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: SCHIZOPHRENIA RESEARCH; v. 195, p. 402-405, MAY 2018.
Web of Science Citations: 1
Abstract

Past studies have linked intracellular pathways related to psychotic disorders to the GSK3B enzyme. This study aimed to investigate GSK3B protein expression and phosphorylation in drug-naive first-episode psychosis patients (n = 43) at baseline and following symptom remission, and in healthy controls (n = 77). At baseline GSK3B total level was higher in patients (p < 0.001). In schizophrenia spectrum patients (n = 25) GSK3B total and phosphorylated levels were higher than in controls and patients with other non-affective psychotic disorders (n = 18) (p < 0.001; p = 0.027; p = 0.05 respectively). No enzyme changes were found after clinical remission. The implication of this finding for the biology of psychoses warrants further studies to clarify whether increased GSK3B may be useful as a biomarker for psychosis in general, and schizophrenia in particular. (C) 2017 Elsevier B.V. All rights reserved. (AU)

FAPESP's process: 13/03905-4 - NEUROBIOLOGICAL DIFFERENCES BETWEEN TREATMENT-NAIVE PATIENTS WITH BIPOLAR DISORDER SUBTYPES I AND II
Grantee:Marcus Vinicius Zanetti
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 13/10350-9 - Proteomics of schizophrenia: the search for biomarkers in platelets
Grantee:Helena Passarelli Giroud Joaquim Nadal
Support Opportunities: Scholarships in Brazil - Doctorate